SCHEMBL5618693

SCHEMBL5618693

C=CCN(F)CCC(N)=O

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9663210 0.78 ALDH1A1 (0.40) ALDH1A1
SCHEMBL3316384 0.75 ALDH1A1 (0.38) ALDH1A1
SCHEMBL10397475 0.69 ALDH1A1 (0.41) ALDH1A1
SCHEMBL15477588 0.69 ALDH1A1 (0.41) ALDH1A1
SCHEMBL10411701 0.69
SCHEMBL1958587 0.68 ALDH1A1 (0.65) ALDH1A1
SCHEMBL8516968 0.68
SCHEMBL316404 0.67 ALDH1A1 (0.76) ALDH1A1
Succinamide SCHEMBL29609508 0.64 LMNA (0.59) ALDH1A1
SCHEMBL241021 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070048246-A1 Novel skin care compositions BIOPHYSICA RESEARCH, INC. (US) 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070048246-A1 Novel skin care compositions CUTA, PLOD3, EBP ALDH1A1 1925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.